Before Adult Approvals, FDA Pushes Pediatric Plans For Cancer Drugs
This article was originally published in The Pink Sheet Daily
Executive Summary
Four products being developed for adult oncology indications will be examined for their pediatric potential at a Dec. 4 meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee.